These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 6109119)
1. Dry artificial lung surfactant and its effect on very premature babies. Morley CJ; Bangham AD; Miller N; Davis JA Lancet; 1981 Jan; 1(8211):64-8. PubMed ID: 6109119 [TBL] [Abstract][Full Text] [Related]
2. Surfactant substitution in the newborn by application of artificial surfactant. Morley CJ J Perinat Med; 1987; 15(5):469-78. PubMed ID: 3327939 [TBL] [Abstract][Full Text] [Related]
3. Effect of exogenous surfactant on total respiratory system compliance. Milner AD; Vyas H; Hopkin IE Arch Dis Child; 1984 Apr; 59(4):369-71. PubMed ID: 6372707 [TBL] [Abstract][Full Text] [Related]
4. Prophylactic treatment of premature babies with artificial surfactant (ALEC). Morley CJ Dev Pharmacol Ther; 1989; 13(2-4):182-3. PubMed ID: 2612300 [TBL] [Abstract][Full Text] [Related]
6. Respiratory compliance in premature babies treated with artificial surfactant (ALEC). Morley CJ; Greenough A Arch Dis Child; 1991 Apr; 66(4):467-71. PubMed ID: 2031602 [TBL] [Abstract][Full Text] [Related]
7. Ten centre trial of artificial surfactant (artificial lung expanding compound) in very premature babies. Ten Centre Study Group. Br Med J (Clin Res Ed); 1987 Apr; 294(6578):991-6. PubMed ID: 2890398 [TBL] [Abstract][Full Text] [Related]
8. Use of surfactant for prophylaxis versus rescue treatment of respiratory distress syndrome: experience from an Italian-Bulgarian trial. Bevilacqua G; Chernev T; Parmigiani S; Iarakova N; Gaioni L; Volante E; Gambini L; Bussolati G Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():47-54. PubMed ID: 10021717 [TBL] [Abstract][Full Text] [Related]
9. Effects of artificial surfactant on lung function and blood gases in idiopathic respiratory distress syndrome. Milner AD; Vyas H; Hopkin IE Arch Dis Child; 1983 Jun; 58(6):458-60. PubMed ID: 6407404 [TBL] [Abstract][Full Text] [Related]
10. Early versus delayed surfactant administration in extremely premature neonates with respiratory distress syndrome ventilated by high-frequency oscillatory ventilation. Plavka R; Kopecký P; Sebron V; Leiská A; Svihovec P; Ruffer J; Dokoupilová M; Zlatohlávková B; Janus V; Keszler M Intensive Care Med; 2002 Oct; 28(10):1483-90. PubMed ID: 12373475 [TBL] [Abstract][Full Text] [Related]
11. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants]. de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193 [TBL] [Abstract][Full Text] [Related]
12. Double-blind, randomized trial of a calf lung surfactant extract administered at birth to very premature infants for prevention of respiratory distress syndrome. Shapiro DL; Notter RH; Morin FC; Deluga KS; Golub LM; Sinkin RA; Weiss KI; Cox C Pediatrics; 1985 Oct; 76(4):593-9. PubMed ID: 3900907 [TBL] [Abstract][Full Text] [Related]
13. Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome. Hoekstra RE; Jackson JC; Myers TF; Frantz ID; Stern ME; Powers WF; Maurer M; Raye JR; Carrier ST; Gunkel JH Pediatrics; 1991 Jul; 88(1):10-8. PubMed ID: 2057245 [TBL] [Abstract][Full Text] [Related]
14. Neonatal respiratory distress syndrome and surfactant therapy; a brief review. Robertson B Eur Respir J Suppl; 1989 Mar; 3():73s-76s. PubMed ID: 2662999 [TBL] [Abstract][Full Text] [Related]
15. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish Multicenter Study Group. Verder H; Robertson B; Greisen G; Ebbesen F; Albertsen P; Lundstrøm K; Jacobsen T N Engl J Med; 1994 Oct; 331(16):1051-5. PubMed ID: 8090164 [TBL] [Abstract][Full Text] [Related]
16. Early or selective surfactant (colfosceril palmitate, Exosurf) for intubated babies at 26 to 29 weeks gestation. A European double-blind trial with sequential analysis. European Exosurf Study Group. Online J Curr Clin Trials; 1992 Nov; Doc No 28():[3886 words; 47 paragraphs]. PubMed ID: 1343614 [TBL] [Abstract][Full Text] [Related]
17. Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks' gestation. Kattwinkel J; Bloom BT; Delmore P; Davis CL; Farrell E; Friss H; Jung AL; King K; Mueller D Pediatrics; 1993 Jul; 92(1):90-8. PubMed ID: 8516091 [TBL] [Abstract][Full Text] [Related]
19. The use of artificial surfactant (ALEC) in the prophylaxis of neonatal respiratory distress syndrome. Morley CJ Eur Respir J Suppl; 1989 Mar; 3():81s-86s. PubMed ID: 2663001 [TBL] [Abstract][Full Text] [Related]
20. Prophylactic treatment of very premature infants with human surfactant. Merritt TA; Hallman M; Bloom BT; Berry C; Benirschke K; Sahn D; Key T; Edwards D; Jarvenpaa AL; Pohjavuori M N Engl J Med; 1986 Sep; 315(13):785-90. PubMed ID: 3528853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]